Invitae, a genetic testing technology spin-out from Genomic Health, had initially raised $101.6m when it floated last week.

The Siemens-backed cancer treatment company, which has raised $195m in funding, will look to raise up to $69m when it floats on Nasdaq.

Sony and Abbott-backed incubator Rainbow Medical has attracted the support of China-based corporates ZTE and Ping An, raising $25m.

Poxel, which is also backed by Bpifrance, will fund clinical trials for two of its drug candidates with the proceeds.

Elasmogen, a biotech spin-out of Aberdeen University, secures US patent for its immunisation technology derived from sharks.

Oxford spin-out Oxehealth successfully concludes trials into baby monitoring.

Novo is among the backers of the life sciences tools company that will focus on acquisitions.

Genomic Health-backed Invitae will offer 6.35 million shares priced at $16, raising $101.6m.